id: extended_release_naltrexone_access_to_opioid_use_disorder_recovery_outcomes
name: Extended-Release Naltrexone (XR-NTX) Access â†’ Opioid Use Disorder Recovery Outcomes
from_node:
  node_id: extended_release_naltrexone_access
  node_name: Extended-Release Naltrexone (XR-NTX) Access
to_node:
  node_id: opioid_use_disorder_recovery_outcomes
  node_name: Opioid Use Disorder Recovery Outcomes
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: XR-NTX provides sustained opioid receptor blockade, preventing euphoric
  effects of opioid use'
- 'Step 2: Monthly injection format eliminates daily adherence challenges common with
  oral medications'
- 'Step 3: Sustained receptor blockade reduces relapse risk and supports abstinence
  maintenance'
- 'Step 4: Improved abstinence and reduced relapse support composite recovery outcomes
  including self-help engagement, employment, and criminal justice outcomes'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Paul Crits-Christoph et al. 2016. "A Naturalistic Evaluation of
    Extended-Release Naltrexone in Clinical Practice in Missouri.." *Journal of substance
    abuse treatment*. https://doi.org/10.1016/j.jsat.2016.07.014
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.691798'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: medication_formulation
  direction: strengthens
  strength: strong
  description: Extended-release formulation significantly superior to oral naltrexone
    on composite outcomes for opioid use disorder
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/extended_release_naltrexone_access_to_opioid_use_disorder_recovery_outcomes.yaml
_category: healthcare_access
